Nikko Asset Management Americas, Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2020$6,350,000
+634900.0%
58,656
-10.4%
0.06%
Q2 2020$1,000
-100.0%
65,463
-71.3%
0.00%
-100.0%
Q1 2020$24,658,000
+67.3%
228,454
+80.3%
0.23%
-0.4%
Q4 2019$14,743,000
-0.5%
126,678
-2.1%
0.23%
-11.8%
Q3 2019$14,818,000
+41.9%
129,445
+18.1%
0.26%
+28.3%
Q2 2019$10,445,000
+110.3%
109,599
+101.4%
0.20%
+56.5%
Q1 2019$4,966,00054,4230.13%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders